Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,483.0
10.7 (0.43%)

 

  • STI Straits Times Index
    2,483.0
    10.7 (0.43%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,511.7
    2.5 (0.17%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,476.0
    240.6 (1.04%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,217.5
    -1.9 (-0.06%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,511.6
    307.0 (1.32%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,906.5
    -39.2 (-0.79%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 764.8M
  • Value: 848.5M
  • Rise: 135
  • Fall: 143
  • Unch: 502

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.053+0.002
Vicplas Intl0.355-0.095
Sembcorp Marine0.143+0.001
OEL0.019+0.001
Singtel2.120-0.020
Synagie0.200-0.010
HPH Trust USD0.136+0.006
Oceanus^0.007-
QT Vascular0.007-
ThaiBev0.595+0.010

World Indices

World Indices
Name Last Change
Nasdaq 10,672.3 +39.3
HSI 23,235.4 -75.7
HSCEI 9,302.6 -68.6
Jakarta 4,945.8 +103.0
Nikkei 225 23,204.6 +116.8
SSE Comp 3,219.4 -3.8
Shanghai A 3,374.1 -4.0
Shanghai B 247.4 +0.8
KOSPI 2,278.8 +6.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

BOSTON SCIENTIFIC CORP BOSTON SCIENTIFIC CORPORATION
Updated on 25 Sep 2020 (End of trading day)
Last (USD): 37.340 Change: +0.220 High: 37.650 Remarks: -
Change (%): +0.59 Low: 36.800
Open 36.890 Yesterday's Close 37.120000000000005
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 7,749,015 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 3.28517 Trailing EPS (USD) e 2.78191 NAV (USD) b 10.9152
PE a 11.366 Trailing PE f 13.422 Price / NAV b 3.4209
Dividend (USD) d - Cash In Hand (USD) g 1.3763 Issued & Paid-up Shares c 1,430,670,000
Dividend Yield (%) d - Price / Cash In Hand g 27.131 Treasury Shares h 247,566,270
Market Cap (M) 53,421.218 Enterprise Value (M) 61,247.218
Piotroski F Score 4 Exchange Code BSX Par Value ( $ ) n.a.
52 Weeks Volatility (%) 43.47 Free Float (%) -
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 06 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference BOSTON SCIENTIFIC CORP NYSE 53,421.218 11.366 13.422 3.4209 -
Industry Medical Specialties NYSE 31,818.807 36.521 41.556 4.2068 0.781
Local Peer ABBOTT LABORATORIES NYSE 183,161.329 49.962 59.603 5.9900 1.270
Local Peer THERMO FISHER SCIENTIFIC INC NYSE 167,053.279 45.198 45.076 5.5917 0.181
Local Peer DANAHER CORP NYSE 146,961.168 59.049 50.310 4.4542 0.322
Local Peer MEDTRONIC PLC NYSE 138,669.735 28.956 31.430 2.7571 2.089
Local Peer STRYKER CORP NYSE 77,002.986 36.967 48.097 6.0376 1.038
Local Peer BECTON DICKINSON & CO NYSE 64,953.846 60.031 83.920 2.7042 1.282
Local Peer EDWARDS LIFESCIENCES CORP NYSE 48,153.840 45.997 64.758 12.5429 -
Local Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 41,070.269 31.443 36.861 3.3388 2.029
Local Peer BAXTER INTERNATIONAL INC NYSE 40,316.316 40.276 43.632 4.9602 1.067
Local Peer AGILENT TECHNOLOGIES INC NYSE 30,118.804 28.122 43.587 6.0467 0.673
Local Peer ZIMMER BIOMET HOLDINGS INC NYSE 27,960.032 24.708 761.854 2.4018 0.707
Local Peer ALCON AG NYSE 27,682.710 - - 1.4746 -
Other Local Peers RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), TELEFLEX INC (NYSE), BIO RAD LABORATORIES INC (NYSE), STERIS PLC (NYSE), PERKINELMER INC (NYSE), QIAGEN NV (NYSE), WATERS CORP (NYSE), PENUMBRA INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), NEVRO CORP (NYSE), HAEMONETICS CORP (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), CONMED CORP (NYSE), GLAUKOS CORPORATION (NYSE), CANTEL MEDICAL CORP (NYSE), AVANOS MEDICAL INC (NYSE), CRYOLIFE INC (NYSE), VAPOTHERM INC (NYSE), INVACARE CORP (NYSE), RA MEDICAL SYSTEMS INC (NYSE)
Global Peer INTUITIVE SURGICAL INC NASDAQ 78,843.927 57.162 69.405 9.0205 -
Global Peer DEXCOM INC NASDAQ 38,522.832 381.037 188.192 28.4532 -
Global Peer IDEXX LABORATORIES INC NASDAQ 32,136.217 75.134 69.846 117.7297 -
Global Peer ALIGN TECHNOLOGY INC NASDAQ 25,048.656 56.572 14.723 8.8043 -
Global Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 23,560.430 72.560 28.162 8.7487 -
Global Peer TOPGLOV Bursa 71,307.291 38.194 38.194 14.2927 1.348
Global Peer Top Glove SGX 23,498.070 38.704 38.702 14.4500 1.333
Global Peer HOLOGIC INC NASDAQ 16,665.685 - 25.243 7.3902 -
Global Peer INSULET CORPORATION NASDAQ 14,703.086 1,267.531 809.998 26.1017 -
Global Peer HARTA Bursa 60,399.321 139.293 107.772 22.2791 0.434
Other Global Peers FISHER & PAYKEL HEALTHCARE CORP (ASX), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), NOVOCURE LTD (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), COCHLEAR LTD (ASX), WEIGAO GROUP (HKEx), QUIDEL CORP (NASDAQ), MICROPORT (HKEx), TANDEM DIABETES CARE INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), BRUKER CORPORATION (NASDAQ), SUPERMX (Bursa), VENUS MEDTECH-B (HKEx), NEOGEN CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), ICU MEDICAL INC (NASDAQ), KANGJI MEDICAL (HKEx), INARI MEDICAL INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), AK MEDICAL (HKEx), STAAR SURGICAL CO (NASDAQ), NUVASIVE INC (NASDAQ), EBOS GROUP (ASX), SHOCKWAVE MEDICAL INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), PEIJIA-B (HKEx), OUTSET MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), ATRICURE INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), CAREDX INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), INMODE LTD (NASDAQ), NANO-X IMAGING LTD (NASDAQ), MESA LABORATORIES INC (NASDAQ), NANOSONICS LIMITED (ASX), CIRC (HKEx), ATRION CORP (NASDAQ), LIFETECH SCI (HKEx), CERUS CORP (NASDAQ), KDL MEDICAL (HKEx), GENMARK DIAGNOSTICS INC (NASDAQ), HESKA CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), SI BONE INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), INOGEN INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), ZYNEX INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), SURMODICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), Medtecs Intl (SGX), VIEWRAY INC (NASDAQ), AXOGEN INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ANTARES PHARMA INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), YESTAR HEALTH (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), UG Healthcare (SGX), MCP INCOME OPPORTUNITIES TRUST (ASX), ANGIODYNAMICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), GOLDEN MEDITECH (HKEx), CUTERA INC (NASDAQ), PROFOUND MED CORP (NASDAQ), CORMEDIX INC (NYSE American), REPRO MEDSYSTEMS INC (NASDAQ), PW MEDTECH (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), AROA BIOSURGERY LTD (ASX), IRADIMED CORP (NASDAQ), STEREOTAXIS INC (NYSE American), MEDICAL DEVELOPMENT INTL (ASX), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), TELA BIO INC (NASDAQ), ALPHA PRO TECH (NYSE American), ACCURAY INCORPORATED (NASDAQ), DERMTECH INC (NASDAQ), MISONIX INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), SIENTRA INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), SOLITON INC (NASDAQ), FONAR CORP (NASDAQ), MODERN DENTAL (HKEx), SOLENO THERAPEUTICS INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ZOSANO PHARMA CORP (NASDAQ), SOMNOMED LIMITED (ASX), CYCLOPHARM LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), DARIOHEALTH CORP (NASDAQ), LKL (Bursa), VINCENT MED (HKEx), INTRICOM CORP (NASDAQ), RESPIRI LTD (ASX), CHEMBIO DIAGNOSTICS INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), PAVMED INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), BIOMERICA INC (NASDAQ), ELECTROMED INC (NYSE American), NEURONETICS INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), ROCKWELL MEDICAL INC (NASDAQ), CONFORMIS INC (NASDAQ), ELECTROCORE INC (NASDAQ), YUNNAN ENERGY (HKEx), ENLIVEX THERAPEUTICS LTD (NASDAQ), Biolidics (SGX), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SDI LTD (ASX), DAXOR CORP (NYSE American), NEPHROS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), TITAN MEDICAL INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), COMPUMEDICS (ASX), NEOVASC INC (NASDAQ), APPLIED UV INC (NASDAQ), MICRO-X LTD (ASX), STRATA SKIN SCIENCES INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), IMPEDIMED LIMITED (ASX), KELFRED (HKEx), OPTISCAN IMAGING (ASX), SENSUS HEALTHCARE INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), RESONANCE HEALTH LTD (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), ONCOCYTE CORP (NYSE American), IMMUCELL CORP (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), INCANNEX HEALTHCARE LTD (ASX), EKSO BIONICS HOLDINGS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), DIMERIX LTD (ASX), APOLLO ENDOSURGERY INC (NASDAQ), Yunnan Energy (SGX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), MOTUS GI HOLDINGS INC (NASDAQ), CARDIEX LTD (ASX), LIFE HEALTHCARE (HKEx), LBT INNOVATIONS LTD (ASX), AVINGER INC (NASDAQ), IRIDEX CORP (NASDAQ), NEUROTROPE INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), BIOLASE INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), METALICITY LIMITED (ASX), CELSION CORPORATION (NASDAQ), CHF SOLUTIONS INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), USCOM LTD (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), CYANOTECH CORP (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), PREDICTIVE ONCOLOGY INC (NASDAQ), ADHERIUM LIMITED (ASX), Annica (SGX), DIGIRAD CORP (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), LIANLUO SMART LIMITED (NASDAQ), STHAI (SET), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), CANCER GENETICS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), NANOVIBRONIX INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), ANALYTICA (ASX), OBALON THERAPEUTICS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), HUAKANG BIOMED (HKEx), DORSAVI LTD (ASX), NEUROTECH INTERNATIONAL LTD (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --1.210
-3.14 %
10 Days --3.780
-9.19 %
20 Days --3.680
-8.97 %
Medium Term Return 3 Months -+2.690
+7.76 %
6 Months -+5.700
+18.02 %
1 Year --3.350
-8.23 %
Long Term Return 2 Years --1.640
-4.21 %
3 Years -+7.870
+26.71 %
5 Years -+20.270
+118.75 %
Annualised Return Annualised --
+16.95 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 24.100 - 46.620 Change From 1 Year Low +13.240 % Change From 1 Year Low (%) +54.94
Change From 1 Year High -9.280 % Change From 1 Year High (%) -19.91
2 Years Range 24.100 - 46.620 Change From 2 Years Low +13.240 % Change From 2 Years Low (%) +54.94
Change From 2 Years High -9.280 % Change From 2 Years High (%) -19.91
5 Years Range 15.670 - 46.620 Change From 5 Years Low +21.670 % Change From 5 Years Low (%) +138.29
Change From 5 Years High -9.280 % Change From 5 Years High (%) -19.91
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
25 Sep 2020 36.890 37.650 36.800 37.340 7,749,015 -
24 Sep 2020 37.430 37.540 36.860 37.120 9,270,464 -
23 Sep 2020 38.660 38.760 37.640 37.720 7,462,004 -
22 Sep 2020 38.510 38.640 37.900 38.600 7,023,929 -
21 Sep 2020 37.830 38.550 37.520 38.550 10,625,530 -
18 Sep 2020 39.600 39.990 38.390 38.480 10,720,380 -
17 Sep 2020 39.920 39.920 39.090 39.670 10,882,940 -
16 Sep 2020 41.240 41.280 39.935 40.190 8,529,988 -
15 Sep 2020 41.330 41.555 40.875 41.020 3,644,812 -
14 Sep 2020 40.660 41.340 40.590 41.120 4,796,849 -
11 Sep 2020 40.950 41.050 39.980 40.290 7,142,888 -
10 Sep 2020 41.580 41.860 40.850 40.970 5,182,694 -
09 Sep 2020 41.270 41.935 41.140 41.530 5,876,911 -
08 Sep 2020 41.060 41.295 40.610 40.920 7,104,882 -
04 Sep 2020 41.590 41.960 40.850 41.480 9,232,448 -
03 Sep 2020 42.150 42.370 41.140 41.490 9,762,785 -
02 Sep 2020 41.500 42.290 41.470 42.230 9,830,290 -
01 Sep 2020 40.700 41.490 40.700 41.470 7,997,272 -
31 Aug 2020 40.930 41.240 40.740 41.020 7,473,590 -
28 Aug 2020 40.710 41.050 40.430 41.030 4,542,190 -
27 Aug 2020 39.400 41.010 39.400 40.780 8,959,493 -
26 Aug 2020 39.690 39.690 38.705 39.350 4,574,120 -
Summary
Current 2 Weeks
(14 Sep 2020 to 25 Sep 2020)
40.660 41.555 36.800 37.340 80,705,911 -
Previous 2 Weeks
(28 Aug 2020 to 11 Sep 2020)
40.710 41.555 36.800 40.290 74,145,950 -
4 Weeks from
(31 Jul 2020 to 27 Aug 2020)
38.840 41.555 36.800 40.780 127,721,557 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.